CHEMILIA AB has a total of 20 patent applications. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CORTEX PHARMA INC, MOORE II BOB M and OPTIKIRA LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Mexico | 2 | |
#8 | Israel | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Johansson Tommy | 19 |
#2 | Dahlstedt Emma | 18 |
#3 | Smitt Olof | 18 |
#4 | Hoegberg Marita | 14 |
#5 | Hogberg Marita | 4 |
#6 | Dahltedt Emma | 1 |
#7 | Högberg Marita | 1 |
Publication | Filing date | Title |
---|---|---|
EP2711364A1 | 4-(Indolyl or benzimidazolyl)amino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer | |
EP2711365A1 | 4-Indazolylamino-2-(2-(indol-3-yl)ethyl)aminopyrimidines useful for the treatment of cancer | |
BR112013024378A2 | new pyrimidine derivatives | |
CA2798578A1 | Novel pyrimidine derivatives | |
EP2502924A1 | Novel pyrimidine derivatives | |
EP2395001A1 | Novel pyrimidine derivatives |